A whistleblower can move forward with a False Claims Act suit alleging that Novartis Pharmaceutical Corp. paid kickbacks to physicians to increase prescriptions of Gilenya, a drug used to treat multiple sclerosis, a New York federal district court said.
Steven Camburn adequately alleged Novartis knowingly submitted kickback-tainted claims to Medicare, including claims alleging Novartis paid physicians for speaking at events with no legitimate attendees, Judge Kimba M. Wood of the US District Court for the Southern District of New York said in a Monday order.
The parties must now work on a proposed schedule for discovery, pretrial motions, and trial, ...
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Log in to keep reading or access research tools and resources.
A video posted to Instagram that appears to show Russian President Vladimir Putin visiting Frankfort, Kentucky, has left some commenters questioning if it's real. The video has over 900 comments an...